Roshni Kulkarni: The Hidden Cost of Underdiagnosed Bleeding Disorders
Roshni Kulkarni, Professor at Michigan State University, shared a post on LinkedIn:
”So glad that the financial impact of delayed diagnosis, under treatment is being recognized.
Thanks Sanjay Ahuja.”
Sanjay Ahuja, Chief Medical Officer at Indiana Hemophilia and Thrombosis Center, shared a post on LinkedIn։
”Women with bleeding disorders remain significantly underdiagnosed and undertreated.
Delays in diagnosis can extend for years, often resulting in repeated emergency visits, chronic anemia, lost productivity and avoidable procedures.
This is not simply a clinical issue. It is a systems and cost issue
Closing this gap for women is not only the right thing to do for patients – it is a high-value, cost-effective investment for any State.”
Stay updated with Hemostasis Today.
-
Aug 26, 2026, 16:32Kai Rejeski: Why TP53 Mutations May Define a Higher-Risk CAR-T Population
-
Aug 26, 2026, 16:20Ons Marsit: Impact of Electroanatomical Mapping on Pentaspline Pulsed Field Ablation
-
Aug 26, 2026, 16:18Sam Mbunya: Celebrating Cyrus Njuguna Githinji’s New Leadership Role in Haemophilia Care
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease
-
Aug 26, 2026, 15:43Laurent Bertoletti: Long Term Benefits and Safety of Rehabilitation in Pulmonary Arterial Hypertension
-
Aug 26, 2026, 15:41Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs